Kidney disease: Improving global outcomes (KDIGO) glomerulonephritis work group. KDIGO clinical practice guideline for glomerulonephritis

Daniel C. Cattran; John Feehally; H. Terence Cook; Zhi Hong Liu; Fernando C. Fervenza; Sergio A. Mezzano; Jürgen Floege; Patrick H. Nachman; Debbie S. Gipson; Manuel Praga; Richard J. Glassock; Jai Radhakrishnan; Elisabeth M. Hodson; Brad H. Rovin; Vivekanand Jha; Stéphan Troyanov; Philip Kam Tao Li; Jack F.M. Wetzels

doi:10.1038/kisup.2012.9

Kidney disease: Improving global outcomes (KDIGO) glomerulonephritis work group. KDIGO clinical practice guideline for glomerulonephritis

Daniel C. Cattran, John Feehally, H. Terence Cook, Zhi Hong Liu, Fernando C. Fervenza, Sergio A. Mezzano, Jürgen Floege, Patrick H. Nachman, Debbie S. Gipson, Manuel Praga, Richard J. Glassock, Jai Radhakrishnan, Elisabeth M. Hodson, Brad H. Rovin, Vivekanand Jha, Stéphan Troyanov, Philip Kam Tao Li, Jack F.M. Wetzels

Research output: Contribution to journal › Article › peer-review

870 Scopus citations

Abstract

The 2011 Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline for Glomerulonephritis (GN) aims to assist practitioners caring for adults and children with GN. Guideline development followed an explicit process of evidence review and appraisal. The guideline contains chapters on various glomerular diseases: steroid-sensitive nephrotic syndrome in children; steroid-resistant nephrotic syndrome in children; minimal-change disease; idiopathic focal segmental glomerulosclerosis; idiopathic membranous nephropathy; membranoproliferative glomerulonephritis; infection-related glomerulonephritis; IgA nephropathy; Henoch-Schönlein purpura nephritis; lupus nephritis; pauci-immune focal and segmental necrotizing glomerulonephritis; and anti-lomerular basement membrane antibody glomerulonephritis. Treatment approaches are addressed in each chapter and guideline recommendations are based on systematic reviews of relevant trials. Appraisal of the quality of the evidence and the strength of recommendations followed the GRADE approach. Limitations of the evidence are discussed and specific suggestions are provided for future research.

Original language	English (US)
Pages (from-to)	139-274
Number of pages	136
Journal	Kidney International Supplements
Volume	2
Issue number	2
DOIs	https://doi.org/10.1038/kisup.2012.9
State	Published - Jun 2012
Externally published	Yes

Keywords

Clinical Practice Guideline
KDIGO
evidence-based recommendation
glomerulonephritis
nephrotic syndrome
systematic review

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access

10.1038/kisup.2012.9

OpenUrl availability

Full text

Cite this

Cattran, D. C., Feehally, J., Cook, H. T., Liu, Z. H., Fervenza, F. C., Mezzano, S. A., Floege, J., Nachman, P. H., Gipson, D. S., Praga, M., Glassock, R. J., Radhakrishnan, J., Hodson, E. M., Rovin, B. H., Jha, V., Troyanov, S., Li, P. K. T., & Wetzels, J. F. M. (2012). Kidney disease: Improving global outcomes (KDIGO) glomerulonephritis work group. KDIGO clinical practice guideline for glomerulonephritis. Kidney International Supplements, 2(2), 139-274. https://doi.org/10.1038/kisup.2012.9

Cattran, DC, Feehally, J, Cook, HT, Liu, ZH, Fervenza, FC, Mezzano, SA, Floege, J, Nachman, PH, Gipson, DS, Praga, M, Glassock, RJ, Radhakrishnan, J, Hodson, EM, Rovin, BH, Jha, V, Troyanov, S, Li, PKT & Wetzels, JFM 2012, 'Kidney disease: Improving global outcomes (KDIGO) glomerulonephritis work group. KDIGO clinical practice guideline for glomerulonephritis', Kidney International Supplements, vol. 2, no. 2, pp. 139-274. https://doi.org/10.1038/kisup.2012.9

@article{1fceb71b940d459aa7c8ea2ff80c8a8c,

title = "Kidney disease: Improving global outcomes (KDIGO) glomerulonephritis work group. KDIGO clinical practice guideline for glomerulonephritis",

abstract = "The 2011 Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline for Glomerulonephritis (GN) aims to assist practitioners caring for adults and children with GN. Guideline development followed an explicit process of evidence review and appraisal. The guideline contains chapters on various glomerular diseases: steroid-sensitive nephrotic syndrome in children; steroid-resistant nephrotic syndrome in children; minimal-change disease; idiopathic focal segmental glomerulosclerosis; idiopathic membranous nephropathy; membranoproliferative glomerulonephritis; infection-related glomerulonephritis; IgA nephropathy; Henoch-Sch{\"o}nlein purpura nephritis; lupus nephritis; pauci-immune focal and segmental necrotizing glomerulonephritis; and anti-lomerular basement membrane antibody glomerulonephritis. Treatment approaches are addressed in each chapter and guideline recommendations are based on systematic reviews of relevant trials. Appraisal of the quality of the evidence and the strength of recommendations followed the GRADE approach. Limitations of the evidence are discussed and specific suggestions are provided for future research.",

keywords = "Clinical Practice Guideline, KDIGO, evidence-based recommendation, glomerulonephritis, nephrotic syndrome, systematic review",

author = "Cattran, {Daniel C.} and John Feehally and Cook, {H. Terence} and Liu, {Zhi Hong} and Fervenza, {Fernando C.} and Mezzano, {Sergio A.} and J{\"u}rgen Floege and Nachman, {Patrick H.} and Gipson, {Debbie S.} and Manuel Praga and Glassock, {Richard J.} and Jai Radhakrishnan and Hodson, {Elisabeth M.} and Rovin, {Brad H.} and Vivekanand Jha and St{\'e}phan Troyanov and Li, {Philip Kam Tao} and Wetzels, {Jack F.M.}",

year = "2012",

month = jun,

doi = "10.1038/kisup.2012.9",

language = "English (US)",

volume = "2",

pages = "139--274",

journal = "Kidney International Supplements",

issn = "2157-1724",

publisher = "Nature Publishing Group",

number = "2",

}

TY - JOUR

T1 - Kidney disease

T2 - Improving global outcomes (KDIGO) glomerulonephritis work group. KDIGO clinical practice guideline for glomerulonephritis

AU - Cattran, Daniel C.

AU - Feehally, John

AU - Cook, H. Terence

AU - Liu, Zhi Hong

AU - Fervenza, Fernando C.

AU - Mezzano, Sergio A.

AU - Floege, Jürgen

AU - Nachman, Patrick H.

AU - Gipson, Debbie S.

AU - Praga, Manuel

AU - Glassock, Richard J.

AU - Radhakrishnan, Jai

AU - Hodson, Elisabeth M.

AU - Rovin, Brad H.

AU - Jha, Vivekanand

AU - Troyanov, Stéphan

AU - Li, Philip Kam Tao

AU - Wetzels, Jack F.M.

PY - 2012/6

Y1 - 2012/6

N2 - The 2011 Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline for Glomerulonephritis (GN) aims to assist practitioners caring for adults and children with GN. Guideline development followed an explicit process of evidence review and appraisal. The guideline contains chapters on various glomerular diseases: steroid-sensitive nephrotic syndrome in children; steroid-resistant nephrotic syndrome in children; minimal-change disease; idiopathic focal segmental glomerulosclerosis; idiopathic membranous nephropathy; membranoproliferative glomerulonephritis; infection-related glomerulonephritis; IgA nephropathy; Henoch-Schönlein purpura nephritis; lupus nephritis; pauci-immune focal and segmental necrotizing glomerulonephritis; and anti-lomerular basement membrane antibody glomerulonephritis. Treatment approaches are addressed in each chapter and guideline recommendations are based on systematic reviews of relevant trials. Appraisal of the quality of the evidence and the strength of recommendations followed the GRADE approach. Limitations of the evidence are discussed and specific suggestions are provided for future research.

AB - The 2011 Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline for Glomerulonephritis (GN) aims to assist practitioners caring for adults and children with GN. Guideline development followed an explicit process of evidence review and appraisal. The guideline contains chapters on various glomerular diseases: steroid-sensitive nephrotic syndrome in children; steroid-resistant nephrotic syndrome in children; minimal-change disease; idiopathic focal segmental glomerulosclerosis; idiopathic membranous nephropathy; membranoproliferative glomerulonephritis; infection-related glomerulonephritis; IgA nephropathy; Henoch-Schönlein purpura nephritis; lupus nephritis; pauci-immune focal and segmental necrotizing glomerulonephritis; and anti-lomerular basement membrane antibody glomerulonephritis. Treatment approaches are addressed in each chapter and guideline recommendations are based on systematic reviews of relevant trials. Appraisal of the quality of the evidence and the strength of recommendations followed the GRADE approach. Limitations of the evidence are discussed and specific suggestions are provided for future research.

KW - Clinical Practice Guideline

KW - KDIGO

KW - evidence-based recommendation

KW - glomerulonephritis

KW - nephrotic syndrome

KW - systematic review

UR - http://www.scopus.com/inward/record.url?scp=84884315497&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84884315497&partnerID=8YFLogxK

U2 - 10.1038/kisup.2012.9

DO - 10.1038/kisup.2012.9

M3 - Article

AN - SCOPUS:84884315497

SN - 2157-1724

VL - 2

SP - 139

EP - 274

JO - Kidney International Supplements

JF - Kidney International Supplements

IS - 2

ER -

Kidney disease: Improving global outcomes (KDIGO) glomerulonephritis work group. KDIGO clinical practice guideline for glomerulonephritis

Abstract

Keywords

UN SDGs

Access

OpenUrl availability

Other files and links

Fingerprint

Cite this